Odonate Therapeutics Inc (ODT)

Common Stock

1.12  -0.05 (-4.27%)

After market: 1.11 -0.01 (-0.89%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2021-9-30)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
2017
(2017-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
90.68M127.43M114.93M90.76M32.74M
Research and Development
71.28M117.04M104.03M79.95M27.90M
Selling, General, and Administrative Expenses
19.40M10.39M10.90M10.82M4.84M
Operating Income
-90.68M-127.43M-114.93M-90.76M-32.74M
Interest Income/Expense
N/AN/A3.11M1.80MN/A
Other Income/Expense
259.00K1.08MN/AN/AN/A
Income Before Taxes
-102.07M-126.35M-111.83M-88.96M-32.74M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-102.07M-126.35M-111.83M-88.96M-32.74M
EBITDA
-90.18M-126.98M-114.55M-90.41M-32.72M
 
Per Share Data
EPS Diluted Total Ops
-2.72-3.85-4.05-3.64-1.22
Non GAAP EPS
-2.68-3.84-4.09-3.63N/A
 
Statistics

All data in USD

Charts